Devices · GE Medical Systems, LLC

SIGNA™ Sprint

GE Medical Systems, LLC is listed for SIGNA™ Sprint (K251399). The FDA list gives September 11, 2025 as the date of the final decision. The lead panel is Radiology, and the database link on the FDA list is the 510(k) pathway. The primary product code on the FDA list is LNH. openFDA did not return a classification record for that code in this copy of the data. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K251399

Official FDA database record

Date of final decision

September 11, 2025

Company on the FDA list

GE Medical Systems, LLC

Lead panel

Radiology

Primary product code

LNH

openFDA device name for the code

System, Nuclear Magnetic Resonance Imaging

Device class

2

Regulation number

892.1000

openFDA decision description

Substantially Equivalent

openFDA decision code

SESE

Statement or summary label

Summary